BIOMAT Database Logo BIOMAT Database Logo

Rational design of high affinity tachykinin NK1 receptor antagonists. 1994

S Boyle, and S Guard, and M Higginbottom, and D C Horwell, and W Howson, and A T McKnight, and K Martin, and M C Pritchard, and J O'Toole, and J Raphy
Parke-Davis Neuroscience Research Centre, Addenbrookes Hospital Site, Cambridge, U.K.

The rational design of a non-peptide tachykinin NK1 receptor antagonist, [(2-benzofuran)-CH2OCO]-(R)-alpha-MeTrp-(S)-NHCH(CH3)P h (28, PD 154075) is described. Compound 28 has a Ki = 9 and 0.35 nM for the NK1 receptor binding site in guinea-pig cerebral cortex membranes and human IM9, cells respectively (using [125I] Bolton-Hunter-SP as the radioligand). It is a potent antagonist in vitro where it antagonises the contractions mediated by SPOMe in the guinea-pig ileum (KB = 0.3 nM). Compound 28 is active in vivo in the guinea-pig plasma extravasation model, where it is able to block the SPOMe-induced protein plasma extravasation (monitored by Evans Blue) in the bladder with an ID50 of 0.02 mg kg-1 iv.

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D001743 Urinary Bladder A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION. Bladder,Bladder Detrusor Muscle,Detrusor Urinae,Bladder Detrusor Muscles,Bladder, Urinary,Detrusor Muscle, Bladder,Detrusor Muscles, Bladder
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Boyle, and S Guard, and M Higginbottom, and D C Horwell, and W Howson, and A T McKnight, and K Martin, and M C Pritchard, and J O'Toole, and J Raphy
High affinity phenylglycinol-based NK1 receptor antagonists.
January 1998, Bioorganic & medicinal chemistry letters,
S Boyle, and S Guard, and M Higginbottom, and D C Horwell, and W Howson, and A T McKnight, and K Martin, and M C Pritchard, and J O'Toole, and J Raphy
Nonpeptide antagonists of the NK1 tachykinin receptor.
July 1996, Medicinal research reviews,
S Boyle, and S Guard, and M Higginbottom, and D C Horwell, and W Howson, and A T McKnight, and K Martin, and M C Pritchard, and J O'Toole, and J Raphy
Gut feelings about tachykinin NK1 receptor antagonists.
April 2001, Trends in pharmacological sciences,
S Boyle, and S Guard, and M Higginbottom, and D C Horwell, and W Howson, and A T McKnight, and K Martin, and M C Pritchard, and J O'Toole, and J Raphy
Pharmacological profiles of new orally active nonpeptide tachykinin NK1 receptor antagonists.
January 1998, European journal of pharmacology,
S Boyle, and S Guard, and M Higginbottom, and D C Horwell, and W Howson, and A T McKnight, and K Martin, and M C Pritchard, and J O'Toole, and J Raphy
Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonist.
May 1997, European journal of pharmacology,
S Boyle, and S Guard, and M Higginbottom, and D C Horwell, and W Howson, and A T McKnight, and K Martin, and M C Pritchard, and J O'Toole, and J Raphy
Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus.
May 1998, European journal of pharmacology,
S Boyle, and S Guard, and M Higginbottom, and D C Horwell, and W Howson, and A T McKnight, and K Martin, and M C Pritchard, and J O'Toole, and J Raphy
Differences in the effects of tachykinin NK1 receptor antagonists: neuronal versus smooth muscle tissues.
November 1993, European journal of pharmacology,
S Boyle, and S Guard, and M Higginbottom, and D C Horwell, and W Howson, and A T McKnight, and K Martin, and M C Pritchard, and J O'Toole, and J Raphy
Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft.
January 2000, British journal of cancer,
S Boyle, and S Guard, and M Higginbottom, and D C Horwell, and W Howson, and A T McKnight, and K Martin, and M C Pritchard, and J O'Toole, and J Raphy
Inhibition of emesis by tachykinin NK1 receptor antagonists in Suncus murinus (house musk shrew).
February 1999, European journal of pharmacology,
S Boyle, and S Guard, and M Higginbottom, and D C Horwell, and W Howson, and A T McKnight, and K Martin, and M C Pritchard, and J O'Toole, and J Raphy
Recent developments in tachykinin NK1 receptor antagonists: prospects for the treatment of migraine headache.
July 1995, Canadian journal of physiology and pharmacology,
Copied contents to your clipboard!